drugset
drugset / Trial / NCT04821323

A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix

NCT04821323 ↗

Phase 0 Completed 10 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to characterize the disruption of intestinal barrier as a result of indomethacin challenge in healthy volunteers using an orally administered lactulose-mannitol test.

Timeline

Start
2021-03-10
Primary completion
2021-05-07
Completion
2021-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule — Oral

Indications

No indication recorded.